Jane Street Group, LLC Cytom X Therapeutics, Inc. Transaction History
Jane Street Group, LLC
- $88.2 Billion
- Q2 2024
A detailed history of Jane Street Group, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 79,701 shares of CTMX stock, worth $95,641. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,701
Previous 183,748
56.62%
Holding current value
$95,641
Previous $400,000
75.75%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CTMX
# of Institutions
76Shares Held
50.2MCall Options Held
22.3KPut Options Held
22.9K-
Tang Capital Management LLC San Diego, CA7.79MShares$9.35 Million1.16% of portfolio
-
Janus Henderson Group PLC London, X06.3MShares$7.56 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$6.27 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$5.87 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3MShares$3.6 Million0.01% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $79.1M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...